Stories Tagged as
Moderna
Vaccine delivery across the country faces complex supply chain challenges
by
Scott Tong
Dec 10, 2020
Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.
Moderna asking U.S., European regulators to OK vaccine
Nov 30, 2020
Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December.
AstraZeneca vaccine is third to show promising data in unprecedented hurry-up race
by
Scott Tong
Nov 23, 2020
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.
How might COVID-19 vaccine makers compete in the marketplace?
by
Andy Uhler
Nov 17, 2020
At first, COVID-19 vaccines won't be marketed in the usual sense, because the government will be the main buyer.